Cooper Companies (The) (COO) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Cooper Companies (The) · Health Care · ref. ETF XLV · 50 calls · price $70.96
What the company does: The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
📈 Cooper Companies (The) (COO) stock price
$70.96+9.9% over range
Aug 28, 25low $58.98 · high $84.32Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
64% recommend buying · 11 analysts
📊 JPI status : Cooper Companies (The) has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 COO price target & analyst consensus — price $70.96
The price target · all analysts combined (11 targets)
Highest target · 1 firm of 11$103+45.2%
Median target · of 11 targets$85+19.8%
Lowest target · 1 firm of 11$66-7.0%
Current price$70.96
Where these 11 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1091%
$71 ↔ $103
Below
19%
$66
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Stifel — 68% of its targets hit on this sector (299 calls tested). It aims for $85 (+20 %), call made on June 6, 2026, maturing on June 6, 2027 (83 d ago).
The 9 reliable analysts
$85+20 %
The 2 other firms
$97.50+37 %
How to read it: the 9 reliable firms are not filtered by optimism — 8 aim above the price, 1 below, hence their $85 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 11 ratings (last 6 months)
Strong Buy00%
Buy764%
Hold436%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 COO price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on COO most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in COO? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Cooper Companies (The)? The JPI assistant answers using our backtest data.
📈 Cooper Companies (The) fundamentals: valuation, margins & growth › open the full page
P/E 61.7Net margin 5.6 %Revenue growth +7.9 %Very high P/E
🔎 Detailed analyses
🏛️ Which US Congress members hold Cooper Companies (The) (COO)?
1 Congress member has disclosed COO buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Gilbert Cisneros 3× · 48%
✅ Historical analyst reliability on COO
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Piper Sandler ↗ | 0% | -7.6% | 2 |
| Baird ↗ | 0% | -10.5% | 2 |
| Wells Fargo ↗ | 0% | -15.8% | 2 |
| Citigroup ↗ | 0% | -16.1% | 2 |
📊 What $1,000 invested in Cooper Companies (The) would be worth › open the full page
In short — $1,000 invested in Cooper Companies (The) 10 years ago would be worth $2,137 today, i.e. +8%/yr on average. Best year: 2016 (+30%), worst: 2022 (-21%). Price performance, excluding dividends.
If I'd invested $1,000 in Cooper Companies (The)
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $780 | -22% |
| 3 years ago | $867 | -13% |
| 5 years ago | $789 | -21% |
Return by year (Cooper Companies (The))
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -13% | $875 (-13%) |
| 2025 | -11% | $780 (-22%) |
| 2024 | -3% | $758 (-24%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Cooper Companies (The)
Loading news…
📋 All analyst calls on COO
Filtered on — · ✕ show all
■ Neutral neutral · not a buy · 🎯$80
Price at call : $76.17 — gap to target +5%
Today : $70.96 — gap to target +13%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Aug 13, 27
matures : Aug 13, 27
■ Neutral neutral · not a buy · 🎯$75
Price at call : $73.06 — gap to target +3%
Today : $70.96 — gap to target +6%
🎯 on COO : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
■ Neutral neutral · not a buy · 🎯$76
Price at call : $71.02 — gap to target +7%
Today : $70.96 — gap to target +7%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
BNP Paribas
Jun 8, 26
▲ Outperform · 🎯$92
Price at call : $68.62 — upside +34%
Today : $70.96 — upside +30%
🎯 on COO : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jun 8, 27
matures : Jun 8, 27
■ Neutral neutral · not a buy · 🎯$71
Price at call : $66.79 — gap to target +6%
Today : $70.96 — gap to target +0%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
▲ Buy · 🎯$85
Price at call : $66.79 — upside +27%
Today : $70.96 — upside +20%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
Wells Fargo ↗
Jun 5, 26
■ Equal-Weight neutral · not a buy · 🎯$66
Price at call : $66.79 — gap to target -1%
Today : $70.96 — gap to target -7%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
▲ Buy · 🎯$86
Price at call : $67.34 — upside +28%
Today : $70.96 — upside +21%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
See the other 42 calls, newest to oldest
▲ Outperform · 🎯$85
Price at call : $67.34 — upside +26%
Today : $70.96 — upside +20%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
▲ Outperform · 🎯$85
Price at call : $67.34 — upside +26%
Today : $70.96 — upside +20%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Piper Sandler ↗
Jun 1, 26
▲ Overweight · 🎯$86
Price at call : $59.49 — upside +45%
Today : $70.96 — upside +21%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jun 1, 27
matures : Jun 1, 27
■ Neutral neutral · not a buy · 🎯$69
Price at call : $61.21 — gap to target +13%
Today : $70.96 — gap to target -3%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
■ Neutral neutral · not a buy · 🎯$87
Price at call : $75.82 — gap to target +15%
Today : $70.96 — gap to target +23%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Mar 6, 27
matures : Mar 6, 27
▲ Overweight · 🎯$103
Price at call : $75.82 — upside +36%
Today : $70.96 — upside +45%
🎯 on COO : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Mar 6, 27
matures : Mar 6, 27
▲ Buy · 🎯$101
Price at call : $76.55 — upside +32%
Today : $70.96 — upside +42%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Mar 6, 27
matures : Mar 6, 27
▲ Buy · 🎯$99
Price at call : $79.33 — upside +25%
Today : $70.96 — upside +40%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
▲ Overweight · 🎯$98
Price at call : $80.7 — upside +21%
Today : $70.96 — upside +38%
🎯 on COO : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jan 26, 27
matures : Jan 26, 27
■ Neutral neutral · not a buy · 🎯$88
Price at call : $78.51 — gap to target +12%
Today : $70.96 — gap to target +24%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Dec 8, 26
matures : Dec 8, 26
Morgan Stanley ↗
Dec 8, 25
■ Equal-Weight neutral · not a buy · 🎯$83
Price at call : $78.51 — gap to target +6%
Today : $70.96 — gap to target +17%
🎯 on COO : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Dec 8, 26
matures : Dec 8, 26
Goldman Sachs ↗
Dec 8, 25
▼ Sell · 🎯$71
Price at call : $78.51 — upside -10%
Today : $70.96 — upside +0%
🎯 on COO : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Dec 8, 26
matures : Dec 8, 26
▲ Buy · 🎯$95
Price at call : $78.04 — upside +22%
Today : $70.96 — upside +34%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
Piper Sandler ↗
Dec 5, 25
▲ Overweight · 🎯$94
Price at call : $78.04 — upside +20%
Today : $70.96 — upside +32%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
Wells Fargo ↗
Dec 5, 25
■ Equal-Weight neutral · not a buy · 🎯$82
Price at call : $78.04 — gap to target +5%
Today : $70.96 — gap to target +16%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
■ Neutral neutral · not a buy · 🎯$78
Price at call : $78.04 — gap to target -0%
Today : $70.96 — gap to target +10%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
▲ Outperform · 🎯$100
Price at call : $81.4 — upside +23%
Today : $70.96 — upside +41%
🎯 on COO : 100% (1 call matured) · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
▲ Outperform · 🎯$98
Price at call : $81.4 — upside +20%
Today : $70.96 — upside +38%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
▲ Buy · 🎯$100
Price at call : $81.4 — upside +23%
Today : $70.96 — upside +41%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
Wells Fargo ↗
Nov 13, 25
■ Equal-Weight neutral · not a buy · 🎯$72
Price at call : $71.75 — gap to target +0%
Today : $70.96 — gap to target +1%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
▲ Overweight · 🎯$85
Price at call : $69.3 — upside +23%
Today : $70.96 — upside +20%
🎯 on COO : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Oct 13, 26
matures : Oct 13, 26
Goldman Sachs ↗
Oct 1, 25
▼ Sell · 🎯$64
Price at call : $69.12 — upside -7%
Today : $70.96 — upside -10%
🎯 on COO : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Oct 1, 26
matures : Oct 1, 26
■ Neutral neutral · not a buy · 🎯$66
Price at call : $67.4 — gap to target -2%
Today : $70.96 — gap to target -7%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Aug 28, 26
matures : Aug 28, 26
Morgan Stanley ↗
Aug 28, 25
■ Equal-Weight neutral · not a buy · 🎯$76
Price at call : $67.4 — gap to target +13%
Today : $70.96 — gap to target +7%
🎯 on COO : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Aug 28, 26
matures : Aug 28, 26
▲ Outperform · 🎯$85
Price at call : $67.4 — upside +26%
Today : $70.96 — upside +20%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Aug 28, 26
matures : Aug 28, 26
Wells Fargo ↗
Aug 28, 25
▲ Overweight · 🎯$72
Price at call : $67.4 — upside +7%
Today : $70.96 — upside +1%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Aug 28, 26
matures : Aug 28, 26
Piper Sandler ↗
Aug 28, 25
▲ Overweight · 🎯$83
Price at call : $67.4 — upside +23%
Today : $70.96 — upside +17%
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Aug 28, 26
matures : Aug 28, 26
▲ Buy · 🎯$85
Price at call : $64.58 — upside +32%
Today : $70.96 — upside +20%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Aug 28, 26
matures : Aug 28, 26
■ Neutral neutral · not a buy · 🎯$72
Price at call : $64.58 — gap to target +11%
Today : $70.96 — gap to target +1%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Aug 28, 26
matures : Aug 28, 26
▲ Buy · 🎯$94
Price at call : $64.58 — upside +46%
Today : $70.96 — upside +32%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Aug 28, 26
matures : Aug 28, 26
▲ Outperform · 🎯$90
Price at call : $72.7 — upside +24%
Today : $70.96 — upside +27%
Expected +24% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on COO : 100% (1 call matured) · 📊 on Health : 52.1% · +3.5% (217 calls)
+0.5%
stock +1% · XLV +21%
matured Jul 16, 26
▲ Buy · 🎯$94
Price at call : $68.76 — upside +37%
Today : $70.96 — upside +32%
Expected +37% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (1 call matured) · 📊 on Health : 50.3% · +4.1% (155 calls)
-5.4%
stock -5% · XLV +13%
matured Jun 17, 26
▲ Outperform · 🎯$97
Price at call : $67 — upside +45%
Today : $70.96 — upside +37%
Expected +45% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51.7% · +6.5% (298 calls)
-10.2%
stock -10% · XLV +11%
matured May 30, 26
Piper Sandler ↗
May 30, 25
▲ Overweight · 🎯$105
Price at call : $67 — upside +57%
Today : $70.96 — upside +48%
Expected +57% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
-10.2%
stock -10% · XLV +11%
matured May 30, 26
Wells Fargo ↗
May 30, 25
▲ Overweight · 🎯$93
Price at call : $67 — upside +39%
Today : $70.96 — upside +31%
Expected +39% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
-10.2%
stock -10% · XLV +11%
matured May 30, 26
■ Neutral neutral · not a buy · 🎯$76
Price at call : $68.28 — gap to target +11%
Today : $70.96 — gap to target +7%
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : May 30, 26
matures : May 30, 26
■ Hold neutral · not a buy
🎯 on COO : 0% (1 call matured) · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : May 30, 26
matures : May 30, 26
■ Hold neutral · not a buy
🎯 on COO : 0% (1 call matured) · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : May 22, 26
matures : May 22, 26
▲ Buy · 🎯$105
Price at call : $79.89 — upside +31%
Today : $70.96 — upside +48%
Expected +31% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (1 call matured) · 📊 on Health : 51.2% · +8.1% (299 calls)
-5.1%
stock -5% · XLV +4%
matured Mar 7, 26
▲ Overweight · 🎯$110
Price at call : $79.89 — upside +38%
Today : $70.96 — upside +55%
Expected +38% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
-5.1%
stock -5% · XLV +4%
matured Mar 7, 26
Piper Sandler ↗
Mar 7, 25
▲ Overweight · 🎯$115
Price at call : $79.89 — upside +44%
Today : $70.96 — upside +62%
Expected +44% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on COO : 0% (2 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
-5.1%
stock -5% · XLV +4%
matured Mar 7, 26
Frequently asked questions
Should I buy Cooper Companies (The) stock?
This isn't buy advice. For Cooper Companies (The), the analyst consensus is "Buy", with an average price target of $85.00 (+20% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 0% of the time (2 calls tracked on Cooper Companies (The)). We show the numbers — you decide.
Is it too late to buy Cooper Companies (The)? How high can it go?
The most bullish analyst target on Cooper Companies (The) is $103 (+45% above today's price); the average is $85.00. That's the upside they see. Check how reliable those analysts have actually been on Cooper Companies (The) on our site before trusting it.
Is Cooper Companies (The) still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 4 analysts have a real record on Cooper Companies (The), the best hitting 0% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Cooper Companies (The)? The case for and against
The arguments for and against, one by one, from the numbers: why invest in COO (and why hesitate).
What has Cooper Companies (The)'s past performance been?
Historical returns and a "how much if I had invested" calculator: COO performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX